NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
The NuvaRing injury case attorneys at the Drug Law Center are currently reviewing and accepting cases involving harm or wrongful death caused by birth control devices.
The unique contraceptive device NuvaRing is a flexible, small ring that is inserted into the vagina as an effective way to prevent pregnancy. Its unique design continuously releases low doses of birth control hormones (estrogen and progestin) to keep a woman’s eggs from leaving her ovaries, thus reducing the possibility of sperm joining the egg. Researchers indicate that the product is 98% to 99% effective. This means that one or two women out of every hundred users could become pregnant accidentally. However, since it was first made available in the medical marketplace, NuvaRing has been associated with a variety of side effects including the potential risks of developing stroke, heart attack, or blood clots.
The History of NuvaRing
Since NuvaRing received its first approval by the Food and Drug Administration, its history has been repeatedly rewritten by the growing number of reports involving heartbreak, controversy, and litigation.
Merck & Company manufactures and markets the vaginal hormone contraceptive device that requires a prescription by a health care provider. In 2001, the U.S. Food and Drug Administration (FDA) approved NuvaRing. Since then, the product has become widely popular. More than a million users have experienced its benefits, and some have been harmed or killed by the product that has generated millions of dollars for the manufacturer.
The flexible plastic contraceptive ring releases a three-week supply of progestin (etonogestrel) and estrogen in a low-dose after the device has been inserted into the vagina. The combination of hormones prevents pregnancy by suppressing ovulation. Manufacturers began using the desogestrel-related etonogestrel in the 1980s believing this advanced designed hormone was far superior to older synthetic hormones because they were thought to reduce the potential risks of unwanted facial hair and acne.
However, the hormone had other potentially life-threatening side effects including strokes, heart attacks, thrombosis, and blood clots. Consumer advocacy groups placed immense pressure on the Food and Drug Administration in an effort to ban any form of contraception using desogestrel. Nearly a decade earlier, the FDA acknowledged that desogestrel products had the potential of increasing the risks of developing blood clots and other life-threatening side effects.
In 2012, the FDA released research information finding that women had a nearly 50% greater chance of developing venous thrombosis (vein-originating blood clots) when compared to women using older versions of birth control hormones. This data was later confirmed in a Danish study involving the risks and effectiveness of NuvaRing.
Who Should Avoid Using NuvaRing?
Like every prescription medication, device, or product, NuvaRing’s specific contraindications that could affect the health and well-being of certain users. Women should avoid using NuvaRing if they have had:
- Malignant or benign liver tumors
- Liver disease
- Are at considerable risk of developing venous arterial thrombotic diseases
- Migraine headaches
- Headaches with focal neurological symptoms
- A coronary artery disease
- A cerebrovascular disease
- Breast cancer
- A confirmation of pregnancy
- Smokers 35 years or older
- A diagnosis of an acquired or inherited hypercoagulopathy
- Diabetes mellitus with vascular disease
- Hypersensitivity to any component or active ingredient in NuvaRing
Women who would use this product concomitantly with the diaphragm should avoid using NuvaRing because it could likely interfere with the correct position or placement of a contraceptive diaphragm.
NuvaRing Side Effects
Many women have experienced minor to serious, life-threatening side effects when using NuvaRing. Less severe NuvaRing side effects include:
- Swollen, tender or painful breasts
- Unexpected loss of appetite
- Unexpected weight loss
- Stomach cramps and bloating
- Dizziness and tired feeling
- Facial skin changes including fracturing and darkening
- Vaginal discharge
- Vaginal itching
- Vaginal irritation
- Vaginal infection
- Increased hair growth
- Hair loss
- Unexpected menstrual period changes
- Decreased libido (low sex drive)
More severe NuvaRing side effects include:
- Blood clots
- Heart attacks
Taking any hormonal birth control, including NuvaRing has the potential of increasing the risk of developing serious blood clots. This risk can be elevated by other risk factors including age (35 years or older), obesity and smoking. Many women have developed deep main thrombosis (DVT), pulmonary embolus (PE), stroke, heart attack, and loss of eyesight. Death and permanent disability are possible when using a NuvaRing contraceptive device as is the development of a stroke, heart attack or blood clot in the brain, heart, eyes, lungs, and legs.
NuvaRing and Hair Loss
The combination of hormones (estrogen and progestin) used in birth control pills and devices, like NuvaRing, are highly effective at preventing pregnancy. However, a can also produce hormonal related hair loss, especially in women predisposed to the condition. In addition, women who have a hypersensitivity to their body’s hormonal changes can lose hair while using the contraceptive or in the weeks or months after the birth control method has been stopped.
Signs and Symptoms
Claims made by plaintiffs filing NuvaRing lawsuits are being confirmed by numerous research studies revealing that the contraceptive device significantly increases the potential risk of developing life-threatening blood clots like deep vein thrombosis and pulmonary embolism. In recent years, hundreds of lawsuits of been filed against Merck & Co. making claims that the patients have suffered severe blood clot injuries including venous thromboembolism, deep vein thrombosis, and pulmonary embolism.
These conditions can be very serious and often lead to a life-threatening stroke or heart attack. This occurs when blood clots form and become lodged in blood streams leading to the brain or heart. DVTs often form in the body’s deep veins typically in the pelvis or legs and can cause leg swelling and pain.
Pulmonary embolism occurs when arteries to the lungs become blocked by a blood clot. Usually, without treatment, the blood clot can easily travel from its origination point to other body parts, including the legs. Venous thromboembolism occurs when the patient is suffering a deep vein thrombosis and a pulmonary embolism at the same time.
Many women suffering serious side effects and adverse reactions have filed a NuvaRing lawsuit against Merck & Company in an effort to obtain the financial compensation they deserve for their damages. Some of these cases involve:
- Illinois Plaintiff Files NuvaRing Lawsuit against Merck & CompanyOctober 2013 – Merck & Company is facing one more NuvaRing lawsuit, this time filed by an Illinois woman alleging that using the product caused her to develop a nearly life-threatening deep main thrombosis (DVT). The plaintiff was first prescribed NuvaRing in December 2007 and used the device up until the end of December 2012. Lawsuit documents reveal that it was only then that she was diagnosed with a deep main thrombosis that requires continuous follow-up care.The plaintiff is claiming that neither her doctor or herself was made aware of the potentially serious side effects including the development of blood clots when using the product. The plaintiff’s attorneys have based the case on Merck’s failure to notify the patient, her doctor, and the medical community of the potentially serious side effects caused by NuvaRing. The lawyers also indicate that Merck failed to provide indications and warnings concerning DVTs on NuvaRing Black Box Warning label.The plaintiff never believed she was in a potential danger of developing a deep main thrombosis and had she understood the possibility of harm that could occur, she would not have used the product and likely chosen another method for birth control. The plaintiff’s attorneys are claiming that Merck is directly financially and legally responsible for every aspect of making, selling, distributing, and marketing the defective devices. The lawyers claim that in Merck’s effort to generate huge profits every year, they concealed information, misrepresented their device, and used false advertising.
- NuvaRing Injury Lawsuit Filed by a Georgia Woman Harmed by the Contraception Device
- November 2013 – Merck & Company has been sued once again over their NuvaRing product, this time by a Georgia woman who alleges her deep main thrombosis (DVT) was caused by using the contraceptive device. Her injuries required hospitalization. The lawsuit document reveals that doctors first prescribed the plaintiff NuvaRing in 2004. The woman claimed she continued used the product until 2007 when she was diagnosed with a DVT after suffering a strokeThe plaintiff’s attorneys are claiming that the woman was never informed by her doctors or the drug manufacturer that the active ingredients in NuvaRing, estrogen and progestin, had the potential of developing blood clots. The plaintiff claims that had she and her physician’s been made aware of the potential risks of using the device, she would have never received the prescription or used the product.The Georgia woman’s attorneys have claimed that the products warning label failed to indicate the potential possibility of serious side effects and that Merck & Co. failed to warn or notify her of the potential problems. The plaintiff indicates that had she been made aware of the side effects she would never have used the contraceptive device.
- Alaska Woman Files a NuvaRing Injury Lawsuit against Merck & CompanyNovember 2013 – Merck & Co., the makers of NuvaRing, are facing another injury lawsuit, this time filed by an Alaskan woman who claims that she sustained injuries and damages after she used NuvaRing. Lawsuit documents reveal that the plaintiff was diagnosed with pulmonary embolism the day after she last took the prescription contraception between November 20, 2006, and December 20, 2006.The plaintiff’s lawyers are indicating that medical testing proved that the woman’s injuries were caused by NuvaRing. The law firm is also saying that the plaintiff and her doctor were never made aware of the potentially serious side effects the product can because. Additionally, the products warning label fails to indicate the potential risk of developing pulmonary embolism. The plaintiff is claiming that had she been made aware she never would’ve taken the product, and never suffered the pulmonary embolism.
We Are Currently Accepting NuvaRing Compensation Cases
Currently, the NuvaRing injury case attorneys at the Drug Law Center are reviewing, evaluating, and accepting lawsuit cases for users of the birth control device. Patients who have suffered a deep main thrombosis, pulmonary embolism, or venous thromboembolism should contact our law firm today. We are currently representing clients in individual lawsuits and the NuvaRing MDL class action lawsuit.
If you believe that you, or someone you love, has suffered a severe injury after using NuvaRing, contact us now to schedule a complimentary, case evaluation. Our attorneys can discuss a potential lawsuit and/or out of court settlement against the drug/device maker, health care providers, and any other party that directly caused your harm.
Our attorneys will assure that you receive the highest level of financial compensation to cover your pain, suffering, disability, ongoing medical expenses, previous hospitalization costs, lost wages, loss of earning capacity, or even a wrongful death. Contact us now to discuss what we can do for you today.